0001752724-22-024600.txt : 20220210 0001752724-22-024600.hdr.sgml : 20220210 20220210122404 ACCESSION NUMBER: 0001752724-22-024600 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211130 FILED AS OF DATE: 20220210 DATE AS OF CHANGE: 20220210 EFFECTIVENESS DATE: 20220210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MASSACHUSETTS INVESTORS GROWTH STOCK FUND CENTRAL INDEX KEY: 0000063090 IRS NUMBER: 041885327 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-00859 FILM NUMBER: 22612466 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 18006372929 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVENUE STREET 2: 21ST FLOOR CITY: BOSTON STATE: MA ZIP: 02199 FORMER COMPANY: FORMER CONFORMED NAME: MASSACHUSETTS INVESTORS GROWTH STOCK FUND INC DATE OF NAME CHANGE: 19920414 0000063090 S000000695 Massachusetts Investors Growth Stock Fund C000002023 A MIGFX C000002024 R3 MIGHX C000002025 R4 MIGKX C000002026 529A EISTX C000002027 529B EMIVX C000002028 529C EMICX C000002029 B MIGBX C000002030 C MIGDX C000002031 I MGTIX C000002034 R1 MIGMX C000002036 R2 MIRGX C000112291 R6 MIGNX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000063090 XXXXXXXX 811-00859 true false false N-1A true MASSACHUSETTS INVESTORS GROWTH STOCK FUND 811-00859 0000063090 IYOONE8CYRIVGIKANH85 111 Huntington Avenue Boston 02199 US-MA US 617-954-5000 Iron Mountain Inc. 1 Federal Street Boston 02110 18008994766 Storage Vendor JPMorgan Chase 270 Park Avenue New York 10017 12122706000 Custodian record Charles River Development 700 District Avenue Burlington 01803 17812380099 Investment related records TerraNua U.S. Corp d.b.a. My Compliance Office 535 5th Avenue 4th floor New York 10017 18669512280 Personal Trading System Massachusetts Financial Services Company 111 Huntington Avenue Boston 02199 16179545000 Investment adviser record MFS Fund Distributors,Inc. 111 Huntington Avenue Boston 02199 16179545000 Principal underwriter record Autonomy Corporation Limited 1140 Enterprise Way Sunnyvale 94089 441223448000 Storage Vendor Institutional Shareholder Services Inc 702 King Farm Boulevard Suite 400 Rockville 20850 13015560500 Proxy voting administrator MFS Service Center Inc. 100 Hancock Street North Quincy 02171 16179545000 Transfer agency record DST Systems,Inc. 333 West 11thStreet Kansas City 64105 18164351000 Technology Vendor The Depository Trust Company 55 Water Street New York 10041 12128551000 DTC Ropes&Gray 800 Boylston Street Boston 02199 16179517000 Counsel record N N N-1A 1 Y John A. Caroselli N/A N Maureen R. Goldfarb N/A N Laurie J. Thomsen N/A N Maryanne L. Roepke N/A N Clarence Otis, Jr. N/A N James W. Kilman, Jr. N/A N Michael W. Roberge N/A Y Peter D. Jones N/A N Steven E. Buller N/A N John P. Kavanaugh N/A N Martin J. Wolin 004331075 111 Huntington Avenue Boston 02199 XXXXXX N N N N N N N MFS FUND DISTRIBUTORS, INC. 8-45321 000031052 N/A Y N ERNST & YOUNG LLP 42 N/A N N N N N N Massachusetts Investors Growth Stock Fund S000000695 IYOONE8CYRIVGIKANH85 N 12 0 0 N/A N N Y N N JPMorgan Chase Bank N.A. 8I5DZWZKVSZI1NUHU748 N N Cash collateral reinvestment fee Revenue sharing split 0.00000000 0.00000000 Rule 17a-7 (17 CFR 270.17a-7) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 22d-1 (17 CFR 270.22d-1) Rule 32a-4 (17 CFR 270.32a-4) Y Y N N MASSACHUSETTS FINANCIAL SERVICES COMPANY 801-17352 000110045 1G3OSH3GLGJ7X1JC5I61 N MFS SERVICE CENTER, INC. 84-1316 N/A Y N N IHS Markit 549300HLPTRASHS0E726 GB N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N Refinitiv U.S. Holdings Inc. 5490300NF240HXJO7N016 N N JPMORGAN CHASE BANK 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N MFS Service Center, Inc. 084-01316 SEC identifier Y N N MASSACHUSETTS FINANCIAL SERVICES 1G3OSH3GLGJ7X1JC5I61 Y N N UBS Securities LLC 8-22651 000007654 T6FIZBDPKLYJKFCRVK44 18379.31000000 Citigroup Global Markets Inc. 8-08177 000007059 MBNUM2BPBDO7JBLYG310 23552.22000000 Jefferies LLC 8-15074 000002347 58PU97L1C0WSRCWADL48 71060.64000000 BMO Capital Markets Corp. 8-34344 000016686 RUC0QBLBRPRCU4W1NE59 54173.62000000 Credit Suisse Securities (USA) LLC 8-00422 000000816 1V8Y6QCX6YMJ2OELII46 19509.16000000 Morgan Stanley & Co. LLC 8-15869 000008209 9R7GPTSO7KV3UQJZQ078 19180.30000000 Goldman Sachs & Co. LLC 8-00129 000000361 FOR8UP27PHTHYVLBNG30 116598.12000000 National Financial Services LLC 8-26740 000013041 549300JRHF1MHHWUAW04 21401.90000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 40485.34000000 Merrill Lynch, Pierce, Fenner & Smith Inc. 8-07221 000007691 8NAV47T0Y26Q87Y0QP81 50096.88000000 509096.21000000 Healthcare of Ontario Pension Plan Trust Fund N/A N/A KRVONIXV1JBEY6WQ6092 CA 240486.66000000 J.P. Morgan Securities LLC 8-35008 000000079 ZBUT11V806EZRVTWT807 1344280.14000000 Manufacturers and Traders Trust Company N/A N/A WWB2V0FCW3A0EE3ZJN75 636.48000000 State Street Global Markets, LLC 8-69862 000285852 549300FDEDF5ORXCMQ56 56962102.00999999 Bank of New York Mellon Corp. N/A N/A WFLLPEPC7FZXENRZV188 966898.62000000 MUFG Securities Americas Inc. 8-43026 000019685 K5HU16E3LMSVCCJJJ255 67442.85000000 59581846.75999999 Y 10488389542.84000000 Uncommitted 200000000.00000000 N Uncommitted 100000000.00000000 N Committed 1250000000.00000000 N N N N false false true false false false INTERNAL CONTROL RPT 2 Mass_Audit_Letter.txt Report of Independent Registered Public Accounting Firm To the Shareholders and Board of Trustees of Massachusetts Investors Growth Stock Fund In planning and performing our audit of the financial statements of Massachusetts Investors Growth Stock Fund (the "Fund") as of and for the year ended November 30, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of November 30, 2021. This report is intended solely for the information and use of management and the Board of Trustees of Massachusetts Investors Growth Stock Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/ Ernst & Young LLP Boston, Massachusetts January 14, 2022